News

The passing week was the time of intense work for the Nestmedic sales team present at the Florida International Medical Expo (FIME) 2018. The event, happening on 17-19 July, results in numerous discussions with the interested parties, mainly from the USA, Colombia, Bolivia, Peru, Venezuela and Israel. Potential partners represent the sector of distributors and medical centers, which are the target groups of clients covered by the Nestmedic business model. On Thursday, July 19, the company’s representatives will conduct workshops devoted to the solution for remote KTG testing offered by Nestmedic. The presentation will be combined with a discussion panel. Friday and Saturday are dedicated to sales meetings in the one-on-one formula organized as part of the economic mission that accompanies FIME 2018.   – Foreign development is a key element of the Nestmedic development strategy this year. Global demand for telemedicine is growing dynamically. We are part of this trend, we reach for new markets. The FIME Fair is a unique opportunity for us to establish business contacts with potential partners – primarily from North America. The United States is the world’s largest market of e-health services estimated at over USD 3.8 billion. The presence of our company in this country is another step in the implementation of the corporate strategy of the Nestmedic Group announced in May this year – says MD, PhD Patrycja Wizińska-Socha, President of the Management Board of Nestmedic S.A. FIME is an international medical fair dedicated to products and services from the market of medical, biomedical, laboratory and healthcare equipment. This year’s edition of FIME is the largest medical fair in the Americas. More information about the event can be found on the website: www.fimeshow.com  

What are the assumptions of the new Nestmedic corporate strategy? Is foreign expansion already taking shape? Where did the decisions about personnel changes in the company come from? – We are at a completely new stage – the stage of intensive commercialization of our solution on foreign markets. The new corporate strategy and changes in the company result from the necessity of effective management of this process – emphasizes the president of Nestmedic. Patrycja Wizińska-Socha in an interview with Inwestorzy.tv also explains that the implementation of the new strategy, assuming expansion in 20 countries around the world, will take 5 years and requires the involvement of high-class specialists. – The first commercial implementations of the Pregnabit system are expected at the end of 2018 – announces the president of Nestmedic. The entire interview is available on YouTube

It is uplifting to receive confirmation that the Pregnabit system is an important and appreciated element of care for mother and her baby. We encourage you to take a quick look on Mrs. Sylwia’s opinion. Pregnabit – I would recommend it to every mother. Our daughter Julia was wrapped around her neck with an umbilical cord. From the moment the device was borrowed, the whole family began to sleep soundly. Daily KTG anytime, anywhere you want. 30 minutes listening to the baby’s heart – something wonderful. Additionally – fast and comfortable contact with doctors who have been monitoring the results of our home tests on an ongoing basis. SMS with description in 1-2 min. from the moment you send the survey. Calm and friendly conversation with the midwife / doctor, even at night. Device really easy to use – our older daughters helped and reminded me about KTG every day. Pregnabit – thank you!!! Robert Woytoń – Thank you for recommending teleKTG. In particular, we as a whole family would like to thank you for conducting pregnancy and professionally made C-section.